CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Beijing Beilu Pharmaceutical Company Limited Company Snapshot
Beijing Beilu Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Beilu Pharmaceutical Company Limited with three other companies in this sector in China: Furen Pharmaceutical Group Industry Co Ltd (2016 sales of 495.63 million Chinese Renmimbi [US$73.24 million] of which 95% was Pharmaceutical Industry), Honz Pharmaceutical Co Ltd (471.46 million Chinese Renmimbi [US$69.67 million] of which 100% was Medical Industry), and Lionco Pharmaceutical Group Co Ltd (478.59 million Chinese Renmimbi [US$70.73 million] of which 100% was Medicine).

Sales Analysis. Beijing Beilu Pharmaceutical Company Limited reported sales of 498.81 million Chinese Renmimbi (US$73.71 million) for the year ending December of 2016. This represents an increase of 2.1% versus 2015, when the company's sales were 488.61 million Chinese Renmimbi. Sales at Beijing Beilu Pharmaceutical Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 154%). Sales of Other Operation saw an increase that was more than double the company's growth rate: sales were up 72.3% in 2016, from 2.76 million Chinese Renmimbi to 4.75 million Chinese Renmimbi. Beijing Beilu Pharmaceutical Company Limited also saw significant increases in sales in Pharmaceutical Sales (up 11.3% to 469.91 million Chinese Renmimbi) . Not all segments of Beijing Beilu Pharmaceutical Company Limited experienced an increase in sales in 2016: sales of Cell Medical Treatment fell 63.6% to 24.20 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing Beilu Pharmaceutical Company Limited
  Stock Performance Chart for Beijing Beilu Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 13.60
(Figures in Chinese Renmimbi)
1 Week -9.5%   13 Weeks -8.4%  
4 Weeks -7.8%   52 Weeks -40.2%  
 
Beijing Beilu Pharmaceutical Company Limited Key Data:
  Ticker: 300016 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 498,809,187
(Year Ending Jan 2017).
Employees: 412
  Currency: Chinese Renmimbi Market Cap: 4,433,508,214
  Fiscal Yr Ends: December Shares Outstanding: 325,993,251
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.